NCT02133755View on ClinicalTrials.gov

Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot Study

PHASE3UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2015

Conditions

PCOSInsulin Resistance

Interventions

DRUG

Bromocriptine

Three month administration of bromocriptine. Baseline ultrasound and laboratory parameters measured. Repeat measures at discontinuation of drug at 3 months.

Trial Locations (1)

B3K 6R8

IWK Health Centre, Halifax